CANCER

Bloodwise 54
Accounting policies for the year ended 31 March 2015
Accounting
policies
BASIS OF ACCOUNTING
The report and accounts are prepared under the
historical cost convention modified to include the
revaluation of investments and in accordance with the
Companies Act 2006, applicable accounting standards
and Accounting and Reporting by Charities; Statement
of Recommended Practice revised 2005 (SORP).
The report and accounts are prepared on the going
concern basis as described in the Report of Trustees on
page 42.
As permitted by section 408 of the Companies Act 2006
and Paragraph 397 of the SORP, no separate Statement
of Financial Activities has been prepared in respect of
Bloodwise.
INCOMING RESOURCES
Legacy income is brought into the accounts when
receivable. This is deemed to be when notice of
impending distribution has been received as at 31
March and the funds have been received or can be
quantified with reasonable certainty by 15 May.
Investment income is brought into the accounts when
receivable.
Income from voluntary Branches and donations from
other voluntary fundraising sources are brought into
the accounts when received at Head Office.
Gift Aid is brought into the accounts on a receivable
basis as part of the income to which it relates.
Fundraising income is shown gross except for small
fundraising events run by volunteers where monies are
received at Head Office net of expenses.
Leukaemia & Lymphoma Research Trading Ltd income
is included when receivable, excluding VAT.
RESOURCES EXPENDED
Costs of generating funds comprises costs associated
with attracting voluntary income and costs of other
income generation e.g. costs of goods sold and other
costs associated with Leukaemia & Lymphoma
Research Trading Ltd. Expenditure is brought into the
accounts when incurred.
Purchase costs and net proceeds of disposal of
investments include the direct costs of investing and
disposing respectively.
Charitable activities expenditure includes expenditure
associated with their performance and comprises
direct expenses including grant awards and staff costs
as well as support costs attributable to these activities.
Research, training and educational grants are included
in the Statement of Financial Activities (SoFA) when
detailed costs are approved by the Board of Trustees.
Clinical trials grants are included in the SoFA when
approved by the Board of Trustees and once the ethical
approval of the final protocol is obtained. Other
charitable expenditure is brought into the accounts
when incurred.
Governance costs include those incurred in the
governance of assets and strategy matters of the
charity, associated with constitutional and statutory
requirements.
Where costs cannot be directly attributed, including
support and central function costs, they have been
allocated to activity cost categories on a basis
consistent with the use of the resources e.g. estimated
time spent or amount used.
Irrecoverable VAT is written off when the expenditure
to which it relates is incurred and is recorded as part of
that expense.
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089
Registered charity 216032 (England & Wales) SC037529 (Scotland)